Northland Capmk Has Negative Outlook of Transcat Q3 Earnings

Transcat, Inc. (NASDAQ:TRNS) – Northland Capmk lowered their Q3 2025 EPS estimates for Transcat in a research report issued on Monday, December 16th. Northland Capmk analyst E. Jackson now anticipates that the scientific and technical instruments company will earn $0.33 per share for the quarter, down from their previous forecast of $0.41. The consensus estimate for Transcat’s current full-year earnings is $1.76 per share. Northland Capmk also issued estimates for Transcat’s Q4 2025 earnings at $0.51 EPS and FY2025 earnings at $1.68 EPS.

TRNS has been the subject of a number of other research reports. Northland Securities lowered their price target on Transcat from $130.00 to $110.00 and set a “market perform” rating for the company in a research report on Wednesday, October 30th. Craig Hallum lifted their target price on Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a report on Thursday, December 12th. HC Wainwright reiterated a “buy” rating and issued a $156.00 price target on shares of Transcat in a report on Tuesday, October 29th. Oppenheimer reissued an “outperform” rating and set a $130.00 price target (down from $155.00) on shares of Transcat in a research report on Wednesday, October 30th. Finally, StockNews.com downgraded shares of Transcat from a “hold” rating to a “sell” rating in a report on Tuesday, October 29th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $130.25.

Transcat Price Performance

Shares of TRNS opened at $106.78 on Wednesday. The company’s fifty day moving average price is $110.27 and its 200-day moving average price is $118.87. Transcat has a 1-year low of $94.29 and a 1-year high of $147.12. The firm has a market capitalization of $982.27 million, a PE ratio of 53.93 and a beta of 0.70.

Transcat (NASDAQ:TRNS) last released its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.12). The company had revenue of $67.83 million for the quarter, compared to analysts’ expectations of $70.30 million. Transcat had a return on equity of 7.36% and a net margin of 6.63%. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.41 EPS.

Hedge Funds Weigh In On Transcat

Several institutional investors have recently made changes to their positions in the company. Conestoga Capital Advisors LLC grew its position in Transcat by 17.9% during the third quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock valued at $109,561,000 after buying an additional 137,830 shares during the period. Champlain Investment Partners LLC boosted its stake in shares of Transcat by 22.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 409,500 shares of the scientific and technical instruments company’s stock worth $49,455,000 after acquiring an additional 74,169 shares in the last quarter. Royce & Associates LP grew its position in shares of Transcat by 8.2% during the 3rd quarter. Royce & Associates LP now owns 511,701 shares of the scientific and technical instruments company’s stock valued at $61,798,000 after acquiring an additional 38,774 shares during the period. Hood River Capital Management LLC increased its stake in shares of Transcat by 21.6% in the 2nd quarter. Hood River Capital Management LLC now owns 196,838 shares of the scientific and technical instruments company’s stock valued at $23,558,000 after purchasing an additional 34,947 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC raised its holdings in Transcat by 28.8% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company’s stock worth $9,577,000 after purchasing an additional 17,743 shares during the period. 98.34% of the stock is owned by hedge funds and other institutional investors.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.